Alliance Pharma plc
APH
Delayed London Stock Exchange - 02/19 05:35:05 pm
67GBp
-0.89%
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 20162017
Sales97,5104
EBITDA26,028,3
Operating profit (EBIT)25,627,5
Pre-Tax Profit (EBT)22,229,0
Net income18,122,8
EPS (GBp )3,824,80
Dividend per Share (GBp )1,211,29
Yield2,55%1,90%
Announcement Date03/29/2017
07:29am
-
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 20162017
Debt76,173,5
Finance--
Operating income (EBITDA)26,028,3
Leverage
(Debt/EBITDA)
2,92x2,60x
Capital Expenditure1,132,23
Book Value Per Share (BVPS)--
Cash Flow per Share--
Announcement Date03/29/2017
07:29am
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 321 M GBP -
Entreprise Value (EV) 395 M GBP 380 M GBP
Valuation 2017e 2018e
P/E ratio (Price / EPS) 14,1x 15,2x
Capitalization / Revenue 3,09x 2,74x
EV / Revenue 3,80x 3,25x
EV / EBITDA 14,0x 11,8x
Yield (DPS / Price) 1,90% 2,14%
Price to book (Price / BVPS) - -
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 26,5% 26,2%
operating Leverage (Delta EBIT / Delta Sales) 1,13x 0,92x
Net Margin (Net Profit / Revenue) 22,0% 18,2%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 10,7% 10,1%
Rate of Dividend 26,8% 32,7%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   2,15% 1,57%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 2,60x 1,83x
Price Earning Ratio
BNA & Dividende